5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Hematopoietic stem cell transplantation (HSCT) can be lifesaving for some of the deadliest hematologic diseases. However, immunosuppression, polypharmacy and risk of infectious complications associated with HSCT can increase morbidity and mortality for recipients. Incidence of acute kidney injury (AKI) after HSCT can be as high as 70%, and concomitant infection can be a therapeutic challenge for oncologists, nephrologists and infectious disease specialists. We illustrate this challenge in the case of a 31-year-old man with acute lymphoblastic leukemia who underwent a double cord HSCT complicated by GvHD, systemic cryptococcal and BK virus infections and AKI. Kidney biopsy showed round to cup-shaped organisms with occasional budding, consistent with Cryptococcus and thrombotic microangiopathy. We discuss our findings and a literature review of disseminated cryptococcal infection with renal involvement after HSCT.

          Related collections

          Author and article information

          Journal
          Bone Marrow Transplant
          Bone marrow transplantation
          Springer Science and Business Media LLC
          1476-5365
          0268-3369
          Oct 2016
          : 51
          : 10
          Affiliations
          [1 ] Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
          [2 ] Division of Renal Diseases and Hypertension, The University of Texas Medical School at Houston, Houston, TX, USA.
          [3 ] Department of Pathology and Laboratory Medicine, The University of Texas Medical School at Houston, Houston, TX, USA.
          [4 ] Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA.
          [5 ] Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
          [6 ] Division of Internal Medicine, Section of Nephrology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
          Article
          bmt2016120
          10.1038/bmt.2016.120
          27159179
          241b5d64-bff8-47fb-ab98-172839afe9fd
          History

          Comments

          Comment on this article